Validation of host cerebrospinal fluid protein biomarkers for early diagnosis of tuberculous meningitis in children: a replication and new biosignature discovery study

References

• Ahmad, R., et al., 2019. A rapid triage test for active pulmonary tuberculosis in adult patients with persistent cough. Science translational medicine, 11 (515), eaaw8287.
   PubMed Web of Science ®Google Scholar
• Bahr, N.C., Nuwagira, E., et al., 2018. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. The lancet. Infectious diseases, 18 (1), 68–75.
   PubMed Web of Science ®Google Scholar
• Bahr, N.C., Halupnick, R., et al., 2018. Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis. Biomarkers in medicine, 12 (7), 707–716.
   PubMed Web of Science ®Google Scholar
• Bahr, N.C., and Boulware, D.R., 2014. Methods of rapid diagnosis for the etiology of meningitis in adults. Biomarkers in medicine, 8 (9), 1085–1103.
   PubMed Web of Science ®Google Scholar
• Bahr, N.C., Meintjes, G., and Boulware, D.R., 2019. Inadequate diagnostics: the case to move beyond the bacilli for detection of meningitis due to Mycobacterium tuberculosis. Journal of medical microbiology, 68 (5), 755–760.
   PubMed Web of Science ®Google Scholar
• Chegou, N.N., et al., 2016. Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB. Thorax, 71 (9), 785–794.
   PubMed Web of Science ®Google Scholar
• Chen, Y., et al., 2016. HMGB1 level in cerebrospinal fluid as a complimentary biomarker for the diagnosis of tuberculous meningitis. SpringerPlus, 5 (1), 1775–1775.
   PubMedGoogle Scholar
• Chendi, B.H., et al., 2021. A plasma 5-marker host biosignature identifies tuberculosis in high and low endemic countries. Frontiers in immunology, 12, 608846.
   PubMed Web of Science ®Google Scholar
• Chiang, S.S., et al., 2014. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. The lancet. Infectious diseases, 14 (10), 947–957.
   PubMed Web of Science ®Google Scholar
• Chin, J.H., et al., 2019. Xpert MTB/RIF ultra for detection of mycobacterium tuberculosis in cerebrospinal fluid. Journal of clinical microbiology, 57 (6), e00249–19.
   PubMed Web of Science ®Google Scholar
• Cresswell, F.V., et al., 2020. Xpert MTB/RIF ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study. The lancet infectious diseases, 20 (3), 308–317.
   PubMed Web of Science ®Google Scholar
• Creswell, J., et al., 2014. Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries. BMC infectious diseases, 14 (1), 2.
   PubMedGoogle Scholar
• Flier, M. v d., et al., 2004. Vascular endothelial growth factor and blood-brain barrier disruption in Tuberculous meningitis. The pediatric infectious disease journal, 23 (7), 608–613.
   PubMed Web of Science ®Google Scholar
• Fluss, R., Faraggi, D., and Reiser, B., 2005. Estimation of the Youden Index and its associated cutoff point. Biom J, 47 (4), 458–472.
   PubMed Web of Science ®Google Scholar
• Husain, N., et al., 2008. Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis. Journal of infection, 56 (2), 114–119.
   PubMed Web of Science ®Google Scholar
• Ingram, G., et al., 2012. Systemic complement profiling in multiple sclerosis as a biomarker of disease state. Multiple sclerosis journal, 18 (10), 1401–1411.
   PubMed Web of Science ®Google Scholar
• Isaiah, S., et al., 2020. Overview of brain-to-gut axis exposed to chronic CNS Bacterial Infection(s) and a predictive urinary metabolic profile of a brain infected by Mycobacterium tuberculosis. Frontiers in neuroscience, 14, 296–296.
   PubMed Web of Science ®Google Scholar
• Jacobs, R., et al., 2016a. Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response. Oncotarget, 7 (36), 57581–57592.
   PubMedGoogle Scholar
• Jacobs, R., et al., 2016b. Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment. Cytokine, 81, 50–56.
   PubMed Web of Science ®Google Scholar
• Karande, S., et al., 2005. Tuberculous meningitis and HIV. The indian journal of pediatrics, 72 (9), 755–760.
   PubMedGoogle Scholar
• Kim, J., et al., 2016. Procalcitonin as a diagnostic and prognostic factor for Tuberculosis Meningitis. Journal of clinical neurology, 12 (3), 332–339.
   PubMed Web of Science ®Google Scholar
• Lawn, S.D., and Nicol, M.P., 2011. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future microbiology, 6 (9), 1067–1082.
   PubMed Web of Science ®Google Scholar
• Li, N., et al., 2017. Association between C4, C4A, and C4B copy number variations and susceptibility to autoimmune diseases: a meta-analysis. Scientific reports, 7 (1), 42628.
   PubMedGoogle Scholar
• MacLean, E., et al., 2019. A systematic review of biomarkers to detect active tuberculosis. Nature microbiology, 4 (5), 748–758.
   PubMed Web of Science ®Google Scholar
• Manyelo, C.M., et al., 2019a. Application of cerebrospinal fluid host protein biosignatures in the diagnosis of Tuberculous meningitis in children from a high burden setting. Mediators of inflammation, 2019, 1–11.
   Web of Science ®Google Scholar
• Manyelo, C.M., et al., 2019b. Potential of Host Serum Protein Biomarkers in the Diagnosis of Tuberculous Meningitis in Children. Frontiers in pediatrics, 7, 376–376.
   PubMed Web of Science ®Google Scholar
• Marais, S., et al., 2010. Tuberculous meningitis: a uniform case definition for use in clinical research. The lancet. Infectious diseases, 10 (11), 803–812.
   PubMed Web of Science ®Google Scholar
• Matsuyama, W., et al., 2001. Expression of vascular endothelial growth factor in tuberculous meningitis. Journal of the neurological sciences, 186 (1–2), 75–79.
   PubMed Web of Science ®Google Scholar
• Merle, N.S., et al., 2015. Complement system Part I – molecular mechanisms of activation and regulation. Frontiers in immunology, 6, 262.
   PubMed Web of Science ®Google Scholar
• Misra, U.K., et al., 2013. Vascular endothelial growth factor in tuberculous meningitis. Int J Neurosci, 123 (2), 128–132.
   PubMed Web of Science ®Google Scholar
• Misra, U.K., et al., 2010. A study of cytokines in tuberculous meningitis: clinical and MRI correlation. Neuroscience letters, 483 (1), 6–10.
   PubMed Web of Science ®Google Scholar
• Mutavhatsindi, H., et al., 2021. Validation and optimization of host immunological bio-signatures for a point-of-care test for TB disease. Frontiers in immunology, 12, 607827.
   PubMed Web of Science ®Google Scholar
• Nhu, N.T.Q., et al., 2014. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. Journal of clinical microbiology, 52 (1), 226–233.
   PubMed Web of Science ®Google Scholar
• Patel, V.B., et al., 2013. Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a high burden setting: a prospective study. PLoS medicine, 10 (10), e1001536.
   PubMed Web of Science ®Google Scholar
• Peng, T., et al., 2014. Detection of Delta-like 1 ligand for the diagnosis of tuberculous meningitis: an effective and rapid diagnostic method. J Int Med Res, 42 (3), 728–736.
   PubMed Web of Science ®Google Scholar
• Pormohammad, A., et al., 2019. A systematic review and meta-analysis of the diagnostic accuracy of nucleic acid amplification tests for Tuberculous meningitis. Journal of clinical microbiology, 57 (6), e01113–18.
   PubMed Web of Science ®Google Scholar
• Reshi, Z., et al., 2017. Cerebrospinal fluid procalcitonin as a biomarker of bacterial meningitis in neonates. Journal of perinatology, 37 (8), 927–931.
   PubMed Web of Science ®Google Scholar
• Seddon, J.A., and Thwaites, G.E., 2019. Tuberculous meningitis: new tools and new approaches required. Wellcome open research, 4, 181.
   PubMedGoogle Scholar
• Solomons, R., et al., 2016. IMCI indicators of childhood TBM at primary health care level in the Western Cape Province of South Africa. The international journal of tuberculosis and lung disease, 20 (10), 1309–1313.
   PubMed Web of Science ®Google Scholar
• Solomons, R.S., et al., 2015. Chest radiograph findings in children with tuberculous meningitis. The international journal of tuberculosis and lung disease, 19 (2), 200–204.
   PubMed Web of Science ®Google Scholar
• Sudbury, E.L., et al., 2019. Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting. Journal of clinical tuberculosis and other mycobacterial diseases, 16, 100102.
   PubMedGoogle Scholar
• Thwaites, G., et al., 2002. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. The lancet, 360 (9342), 1287–1292.
   PubMed Web of Science ®Google Scholar
• Visser, D.H., et al., 2015. Host immune response to tuberculous meningitis. Clin Infect Dis, 60 (2), 177–187.
   PubMed Web of Science ®Google Scholar
• Wang, H., and Liu, M., 2021. Complement C4, infections, and autoimmune diseases. Frontiers in immunology, 12, 694928.
   PubMedGoogle Scholar
• Wei, T.-T., et al., 2016. Diagnostic accuracy of procalcitonin in bacterial meningitis versus nonbacterial meningitis: a systematic review and meta-analysis. Medicine, 95 (11), e3079.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2021. Global tuberculosis report 2021. Geneva: World Health Organisation.
   Google Scholar
• World Health Organization. 2018. Roadmap towards ending TB in children and adolescents, second edition. Geneva: World Health Organization.
   Google Scholar
• World Health Organization, 2017. Next-generation Xpert® MTB/RIF Ultra assay recommended by WHO [online]. Available from: https://www.who.int/news/item/25-03-2017-next-generation-xpert-mtb-rif-ultra-assay-recommended-by-who [Accessed 8 Jun 2021].
   Google Scholar
• World Health Organization. 2014., High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting. Geneva, Switzerland: World Health Organization.
   Google Scholar
• Xu, D., et al., 2015. Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics, 15 (1), 58–67.
   PubMed Web of Science ®Google Scholar